BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16182380)

  • 1. Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma.
    Monteiro de Almeida S; Letendre S; Zimmerman J; Lazzaretto D; McCutchan A; Ellis R
    J Neuroimmunol; 2005 Dec; 169(1-2):144-52. PubMed ID: 16182380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of CSF leukocytosis to compartmentalized changes in MCP-1/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy.
    Monteiro de Almeida S; Letendre S; Zimmerman J; Kolakowski S; Lazzaretto D; McCutchan JA; Ellis R
    J Neuroimmunol; 2006 Oct; 179(1-2):180-5. PubMed ID: 16901548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The monocyte chemotactic protein-1 -2578G allele is associated with elevated MCP-1 concentrations in cerebrospinal fluid.
    Letendre S; Marquie-Beck J; Singh KK; de Almeida S; Zimmerman J; Spector SA; Grant I; Ellis R;
    J Neuroimmunol; 2004 Dec; 157(1-2):193-6. PubMed ID: 15579297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and virological correlation between the cerebrospinal fluid and blood of HIV-infected children].
    Sáez-Llorens X; Castrejón de Wong MC; Castaño E; de Suman O; Báez de Ulloa C; Redondo W; Espino M
    Rev Med Panama; 2001; 26():13-8. PubMed ID: 16161718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure.
    Spudich S; Lollo N; Liegler T; Deeks SG; Price RW
    J Infect Dis; 2006 Dec; 194(12):1686-96. PubMed ID: 17109340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting.
    Rawson T; Muir D; Mackie NE; Garvey LJ; Everitt A; Winston A
    J Infect; 2012 Sep; 65(3):239-45. PubMed ID: 22522289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid and plasma concentrations of proinflammatory mediators in human immunodeficiency virus-infected children.
    McCoig C; Castrejón MM; Saavedra-Lozano J; Castaño E; Báez C; Lanier ER; Sáez-Llorens X; Ramilo O
    Pediatr Infect Dis J; 2004 Feb; 23(2):114-8. PubMed ID: 14872175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.
    McArthur JC; McDermott MP; McClernon D; St Hillaire C; Conant K; Marder K; Schifitto G; Selnes OA; Sacktor N; Stern Y; Albert SM; Kieburtz K; deMarcaida JA; Cohen B; Epstein LG
    Arch Neurol; 2004 Nov; 61(11):1687-96. PubMed ID: 15534180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cerebrospinal fluid viral load in HIV-1 positive hemophilic patients treated with HAART].
    Corti ME; Villafañe MF; Baré P; Alves Rosa F; Cermelj M; Candela M; Pérez Bianco R; Tezanos Pinto M
    Medicina (B Aires); 2001; 61(6):821-4. PubMed ID: 11808421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of a monocyte chemoattractant protein 1 mutated allele on the response to protease inhibitor-based antiretroviral therapy.
    Coll B; Alonso-Villaverde C; Parra S; Rabassa A; Martorell L; Joven J; Masana L
    HIV Med; 2006 Sep; 7(6):356-60. PubMed ID: 16903979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people.
    Vitiello B; Goodkin K; Ashtana D; Shapshak P; Atkinson JH; Heseltine PN; Eaton E; Heaton R; Lyman WD
    AIDS; 2007 Jul; 21(11):1415-22. PubMed ID: 17589187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus-1 RNA levels in cerebrospinal fluid exhibit a set point in clinically stable patients not receiving antiretroviral therapy.
    Ellis RJ; Childers ME; Zimmerman JD; Frost SD; Deutsch R; McCutchan JA;
    J Infect Dis; 2003 Jun; 187(11):1818-21. PubMed ID: 12751041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical importance of the quantification of HIV-1 RNA in cerebrospinal fluid for the diagnosis of HIV encephalitis].
    Bossi P; Dupré S; Dupin N; Coutellier A; Bricaire F; Lubetzki C; Katlama C; Calvez V
    Pathol Biol (Paris); 1998 Jun; 46(6):423-5. PubMed ID: 9769875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpretation of high levels of HIV-1 RNA in the cerebrospinal fluid (CSF) using amplicor HIV-1 monitor test.
    Honderlick P; Zucman D; Couderc LJ
    Pathol Biol (Paris); 1999 May; 47(5):560-2. PubMed ID: 10418040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.
    Sevigny JJ; Albert SM; McDermott MP; McArthur JC; Sacktor N; Conant K; Schifitto G; Selnes OA; Stern Y; McClernon DR; Palumbo D; Kieburtz K; Riggs G; Cohen B; Epstein LG; Marder K
    Neurology; 2004 Dec; 63(11):2084-90. PubMed ID: 15596754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection.
    Cinque P; Bestetti A; Marenzi R; Sala S; Gisslen M; Hagberg L; Price RW
    J Neuroimmunol; 2005 Nov; 168(1-2):154-63. PubMed ID: 16091292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of simian immunodeficiency virus populations in blood and cerebrospinal fluid over the full course of infection.
    Harrington PR; Connell MJ; Meeker RB; Johnson PR; Swanstrom R
    J Infect Dis; 2007 Oct; 196(7):1058-67. PubMed ID: 17763329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of cerebrospinal fluid: potential for the study of HIV-1 infection of the central nervous system.
    Cinque P; Bestetti A; Morelli P; Presi S
    J Neurovirol; 2000 May; 6 Suppl 1():S95-S102. PubMed ID: 10871772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal comparison of HIV-1 RNA burden in plasma and cerebrospinal fluid in two patients starting triple combination antiretroviral therapy.
    Iftimovici E; Rabian C; Burgard M; Peytavin G; Rouzioux C; Viard JP
    AIDS; 1998 Mar; 12(5):535-7. PubMed ID: 9543456
    [No Abstract]   [Full Text] [Related]  

  • 20. Difference in drug resistance patterns between minor HIV-1 populations in cerebrospinal fluid and plasma.
    Bergroth T; Ekici H; Gisslén M; Hagberg L; Sönnerborg A
    HIV Med; 2009 Feb; 10(2):111-5. PubMed ID: 19200174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.